Belizatinib (TSR-011)

A potent ALK inhibitor



BV-B2028-5	5 mg	160.00 USD

BV-B2028-25	25 mg	633.00 USD

Belizatinib (TSR-011) is a potent inhibitor of both the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and the tropomyosin-related kinases (TRK) TRKA, TRKB, and TRKC, with potential antineoplastic activity. The inhibition leads to disruption of ALK- and TRK-mediated signaling and impedes tumor cell growth in ALK/TRK-overexpressing tumor cells.

PRODUCT PROPERTIES
Formula:		C₃₃H₄₄FN₅O₃
MW:		577.75
CAS:		1357920-84-3
Purity:		≥98% by HPLC
Appearance:		Crystalline solid
Solubility:		DMSO
Long Term Storage:		-20°C
Background / Technical Information:		For the Original Manufacturer's data sheet please click here.

TECHNICAL DOCUMENTS Print as PDF	RELATED PRODUCTS No related products available
PRODUCT SUPPORT Technical Service Bulk Quantity Quote Customer Service	CATALOG SECTION

Belizatinib (TSR-011)

TECHNICAL DOCUMENTS

RELATED PRODUCTS

PRODUCT SUPPORT

CATALOG SECTION